re;
$KIN 07-29-2020 btm.Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart
May 20, 2020
San Francisco, California (May 20, 2020) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company developing novel biologics,
today announced it has entered into an agreement with Vaxart, Inc. (Nasdaq: VXRT) for the manufacture of Vaxart’s oral vaccine candidate for COVID-19.
“We are proud to be contributing toward the effort to develop a COVID-19 vaccine.
We look forward to working with Vaxart to bring this innovative technology to patients as quickly as possible,” said KindredBio’s Chief Executive Officer,
Richard Chin, M.D.
“This marks an important step in the development of our contract manufacturing business, which has the potential to help fund our promising pipeline.”
Under the terms of the agreement, KindredBio will provide manufacturing services from its state-of-the-art biological development and cGMP manufacturing facility in Burlingame, CA.
There, KindredBio will produce the candidate vaccine bulk drug substance under Good Manufacturing Practices,
and provide it to Vaxart to be
formulated into a vaccine tablet to be taken by mouth
instead of by needle injection.
KindredBio will manufacture the vaccine for clinical trials beginning in the second half of 2020.
“We are pleased to be partnering with Kindred Biosciences in the development of our oral COVID-19 vaccine candidate,” said Vaxart’s Chief Executive Officer,
Wouter Latour, M.D.
“We believe our novel approach utilizing a room temperature-stable tablet offers important logistical advantages in widespread oral vaccination,
and that KindredBio with its state-of-the-art manufacturing plants is
an ideal partner to realize our vision.”
KindredBio’s core expertise includes protein engineering,
cell line development,
master cell banking, process development, assay development, stability testing, and
cGMP clinical and
commercial manufacturing from 50 litres to 2,000 litres.
Recent KIN News
- Business update premier trimestre 2024 • GlobeNewswire Inc. • 04/25/2024 05:00:00 AM
- Business update first quarter 2024 • GlobeNewswire Inc. • 04/25/2024 05:00:00 AM
- Publication du rapport annuel 2023 et convocation à l’Assemblée générale • GlobeNewswire Inc. • 04/05/2024 05:59:59 AM
- Publication of annual report 2023 and convening notice for the General Meeting • GlobeNewswire Inc. • 04/05/2024 05:59:59 AM
- Kinepolis a enregistré des résultats records en 2023 • GlobeNewswire Inc. • 02/22/2024 06:00:00 AM
- Kinepolis achieved record results in 2023 • GlobeNewswire Inc. • 02/22/2024 06:00:00 AM
- Mise à jour et fin du programme de rachat d'actions propres (19 février 2024) • GlobeNewswire Inc. • 02/19/2024 04:45:05 PM
- Update and end of the share buyback program (19 February 2024) • GlobeNewswire Inc. • 02/19/2024 04:45:05 PM
- Update share buyback program (12 February 2024) • GlobeNewswire Inc. • 02/12/2024 04:45:07 PM
- Mise à jour concernant le programme de rachat d'actions propres (12 février 2024) • GlobeNewswire Inc. • 02/12/2024 04:45:07 PM
- Mise à jour concernant le programme de rachat d'actions propres (5 février 2024) • GlobeNewswire Inc. • 02/05/2024 04:47:42 PM
- Update share buyback program (5 February 2024) • GlobeNewswire Inc. • 02/05/2024 04:47:42 PM
- Update share buyback program (29 January 2024) • GlobeNewswire Inc. • 01/29/2024 04:45:05 PM
- Mise à jour concernant le programme de rachat d'actions propres (29 janvier 2024) • GlobeNewswire Inc. • 01/29/2024 04:45:05 PM
- Mise à jour concernant le programme de rachat d'actions propres (22 janvier 2024) • GlobeNewswire Inc. • 01/22/2024 04:45:00 PM
- Update share buyback program (22 January 2024) • GlobeNewswire Inc. • 01/22/2024 04:45:00 PM
- Update share buyback program (15 January 2024) • GlobeNewswire Inc. • 01/15/2024 04:45:18 PM
- Mise à jour concernant le programme de rachat d'actions propres (15 janvier 2024) • GlobeNewswire Inc. • 01/15/2024 04:45:18 PM
- Publication of a transparency notification • GlobeNewswire Inc. • 01/11/2024 05:02:45 PM
- Publication relative à une notification de transparence • GlobeNewswire Inc. • 01/11/2024 05:02:45 PM
- Update share buyback program (8 January 2024) • GlobeNewswire Inc. • 01/08/2024 04:45:00 PM
- Mise à jour concernant le programme de rachat d'actions propres (8 janvier 2024) • GlobeNewswire Inc. • 01/08/2024 04:45:00 PM
- Update share buyback program (3 January 2024) • GlobeNewswire Inc. • 01/03/2024 04:45:51 PM
- Mise à jour concernant le programme de rachat d'actions propres (3 janvier 2024) • GlobeNewswire Inc. • 01/03/2024 04:45:51 PM
- Mise à jour concernant le programme de rachat d'actions propres (26 décembre 2023) • GlobeNewswire Inc. • 12/26/2023 04:45:00 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM